Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kornelius Schulze

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Hepatic Oncology|September 8, 2018
Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practiceKornelius Schulze, Jessica Zucman-Rossi
Molecular & Cellular Oncology|September 22, 2016
Translating the molecular diversity of hepatocellular carcinoma into clinical practiceKornelius Schulze, Jessica Zucman-Rossi
Journal of Hepatology|June 6, 2016
Genetic profiling of hepatocellular carcinoma using next-generation sequencingKornelius Schulze, Jean-Charles Nault, Augusto Villanueva
European Journal of Medical Genetics|August 21, 2021
Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomasHenning Wege, Kornelius Schulze, Johann von Felden, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 21, 2016
CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel diseaseKornelius Schulze, Nadine Koppka, Frederik Lutter, et al.
Diagnostics (Basel, Switzerland)|December 6, 2016
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response EvaluationJohann von Felden, Kornelius Schulze, Ines Gil-Ibanez, et al.
Gut|September 5, 2020
Liquid biopsy in the clinical management of hepatocellular carcinomaJohann von Felden, Teresa Garcia-Lezana, Kornelius Schulze, et al.
International Journal of Cancer|April 26, 2013
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinomaKornelius Schulze, Christin Gasch, Katharina Staufer, et al.
BMC Cancer|January 20, 2017
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resectionJohann von Felden, Denise Heim, Kornelius Schulze, et al.
Viruses|May 28, 2025
Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCCJanine Kah, Lisa Staffeldt, Tassilo Volz, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Hepatic Oncology|September 8, 2018
Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practiceKornelius Schulze, Jessica Zucman-Rossi
Molecular & Cellular Oncology|September 22, 2016
Translating the molecular diversity of hepatocellular carcinoma into clinical practiceKornelius Schulze, Jessica Zucman-Rossi
Journal of Hepatology|June 6, 2016
Genetic profiling of hepatocellular carcinoma using next-generation sequencingKornelius Schulze, Jean-Charles Nault, Augusto Villanueva
European Journal of Medical Genetics|August 21, 2021
Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomasHenning Wege, Kornelius Schulze, Johann von Felden, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 21, 2016
CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel diseaseKornelius Schulze, Nadine Koppka, Frederik Lutter, et al.
Diagnostics (Basel, Switzerland)|December 6, 2016
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma-An Update on Patient Selection and Response EvaluationJohann von Felden, Kornelius Schulze, Ines Gil-Ibanez, et al.
Gut|September 5, 2020
Liquid biopsy in the clinical management of hepatocellular carcinomaJohann von Felden, Teresa Garcia-Lezana, Kornelius Schulze, et al.
International Journal of Cancer|April 26, 2013
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinomaKornelius Schulze, Christin Gasch, Katharina Staufer, et al.
BMC Cancer|January 20, 2017
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resectionJohann von Felden, Denise Heim, Kornelius Schulze, et al.
Viruses|May 28, 2025
Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCCJanine Kah, Lisa Staffeldt, Tassilo Volz, et al.
Pageof 6